Beyond government intervention: Drug companies and bioethics
American Journal of Bioethics 2 (3):42 – 43 (2002)
| Abstract | This Article does not have an abstract | |||||||||
| Keywords | No keywords specified (fix it) | |||||||||
| Categories | ||||||||||
| Options |
|
|||||||||
| PhilPapers Archive |
Upload a copy of this paper Check publisher's policy on self-archival Papers currently archived: 5,701 |
| External links |
|
| Through your library | Configure |
Peter R. Mansfield (2005). Banning All Drug Promotion is the Best Option Pending Major Reforms. Journal of Bioethical Inquiry 2 (2).
Jeff McMahan (2009). Humanitarian Intervention, Consent, and Proportionality. In N. Ann Davis, Richard Keshen & Jeff McMahan (eds.), Ethics and Humanity: Themes From the Philosophy of Jonathan Glover. Oxford University Press.
Kelly Brownell (2010). Government Intervention and The Nation's Diet: The Slippery Slope of Inaction. American Journal of Bioethics 10 (3):1-2.
Deane-Peter Baker & James Pattison (2011). The Principled Case for Employing Private Military and Security Companies in Interventions for Human Rights Purposes. Journal of Applied Philosophy 29 (1):1-18.
Dan W. Brock (2001). Some Questions About the Moral Responsibilities of Drug Companies in Developing Countries. Developing World Bioethics 1 (1):33-37.
Anthony Vernillo (2009). Disclosure of Adverse Clinical Trial Results—Should Legal Immunity Be Granted to Drug Companies? American Journal of Bioethics 9 (8):45-47.
Allan S. Brett (2003). Cheap Trinkets, Effective Marketing: Small Gifts From Drug Companies to Physicians. American Journal of Bioethics 3 (3):52-54.
Yongqiang Gao (2011). Government Intervention, Perceived Benefit, and Bribery of Firms in Transitional China. Journal of Business Ethics 104 (2):175-184.
Monthly downloads |
Added to index2009-01-28Total downloads3 ( #202,008 of 549,093 )Recent downloads (6 months)1 ( #63,361 of 549,093 )How can I increase my downloads? |

